Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in japanese patients with type 2 diabetes mellitus

Highlights • Small dense LDL-C (sd LDL-C) convey cardiovascular risk in type 2 diabetes (T2D). • Ipragliflozin reduced sd LDL-C levels in Japanese patients with T2D. • Changes in body weight, TG and LDL-C levels contributed to sd LDL-C reduction.

Saved in:
Bibliographic Details
Published in:Journal of clinical & translational endocrinology 2016-12, Vol.6 (C), p.1-7
Main Authors: Bando, Yukihiro, Tohyama, Hitomi, Aoki, Keiko, Kanehara, Hideo, Hisada, Azusa, Okafuji, Kazuhiro, Toya, Daisyu
Format: Article
Language:English
Subjects:
Endocrinology & Metabolism
Ipragliflozin
Research Paper
Small dense LDL cholesterol
Type 2 diabetes mellitus
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Small dense LDL-C (sd LDL-C) convey cardiovascular risk in type 2 diabetes (T2D). • Ipragliflozin reduced sd LDL-C levels in Japanese patients with T2D. • Changes in body weight, TG and LDL-C levels contributed to sd LDL-C reduction.
ISSN:2214-6237
2214-6237
DOI:10.1016/j.jcte.2016.06.001